NCT06831435

Brief Summary

The project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapists, which is conducted for a total of 8 weeks, with weekly sessions including AI-guided course work and homework. This study aims to evaluate the therapeutic effects of CBT-based digital products for depression in patients through a real-world study, and to explore its genetic and neuroimaging mechanisms.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
325

participants targeted

Target at P75+ for not_applicable depression

Timeline
8mo left

Started Nov 2024

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Nov 2024Dec 2026

Study Start

First participant enrolled

November 13, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 18, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

February 12, 2025

Last Update Submit

December 8, 2025

Conditions

Keywords

i-CBTa real-world study

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Hamilton Depression Rating Scale (HAMD)

    The outcome is assessed by 17-item Hamilton Depression Rating Scale (HAMD-17) Scale. Total HAMD scores range from 0 to 52, with higher scores indicating more severe depressive symptoms. The change of HAMD from baseline to 8-week (after intervention) was used as the primary outcome.

    Week 4 and 8 of treatment duration

Secondary Outcomes (13)

  • Change from baseline in Montgomery-Asberg Depression Rating Scale (MADRS)

    Week 4 and 8 of treatment duration

  • Change from baseline in Positive and Negative Syndrome Scale (PANSS)

    Week 4 and 8 of treatment duration

  • Response to treatment

    Week 4 and 8 of treatment duration

  • Clinical Global Impression-Severity of Illness (CGI-S)

    Week 4 and 8 of treatment duration

  • Change from baseline in Hamilton Anxiety Rating Scale (HAMA)

    Week 4 and 8 of treatment duration

  • +8 more secondary outcomes

Study Arms (1)

i-CBT group

EXPERIMENTAL

i-CBT combined with conventional drug treatment

Device: a digital product based on CBT

Interventions

The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapists, which is conducted for a total of 8 weeks, with weekly sessions including Al-guided course work and homework.

i-CBT group

Eligibility Criteria

Age14 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 14-60 years (including 14 and 60), no gender restriction;
  • HAMD \>= 14;
  • Written informed consent obtained from the patient; written informed consent obtained from the guardian for minors.

You may not qualify if:

  • Persons with severe suicidal tendencies (item 10 of the MADRS scale ≥ 5).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Sixth Hostipal

Beijing, Beijing Municipality, 100191, China

RECRUITING

MeSH Terms

Conditions

DepressionBipolar Disorder

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorBipolar and Related DisordersMood DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 12, 2025

First Posted

February 18, 2025

Study Start

November 13, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 15, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations